ADIM
RVTY icon

Alpha DNA Investment Management’s Revvity RVTY Stock Holding History

Alpha DNA Investment Management’s Portfolio RVTY Stock Details RVTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,009
Closed -$1.28M – 191
2022
Q2 		$1.28M Buy
+9,009
New +$1.35M 1.09% 5
2021
Q2 		– Sell
-37
Closed -$4K – 540
2021
Q1 		$4K Buy
37
+18
+95% +$2.49K ﹤0.01% 421
2020
Q4 		$2K Buy
+19
New +$2.53K ﹤0.01% 482

Other funds holding RVTY

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's RVTY Position: Q3 2022 in Review

Alpha DNA Investment Management sold out of Revvity (RVTY) in Q3 2022, closing a stake of 9,009 shares — an estimated $1.28M sold.

Alpha DNA Investment Management first reported a position in RVTY in Q4 2020 and held it in 3 quarters. The position peaked at $1.28M in Q2 2022. 548 funds tracked by Wall St. Rank hold RVTY as of Q3 2022.

  • Alpha DNA Investment Management reported no remaining Revvity position as of Q3 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9,009 Revvity shares in Q3 2022, an estimated $1.28M.
  • Alpha DNA Investment Management first reported a position in Revvity in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Revvity position peaked at $1.28M in Q2 2022.
  • 548 funds tracked by Wall St. Rank held Revvity as of Q3 2022.

Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.